European Journal of Oncology Nursing
Volume 13, Issue 1 , Pages 9-15, February 2009

Olfactory changes among patients receiving chemotherapy

  • Britt-Marie Bernhardson

      Affiliations

    • Department NVS, Division of Nursing, Karolinska Institutet, Stockholm, Sweden
    • R & D Unit, Stockholms Sjukhem Foundation, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. R&D Unit, Stockholms Sjukhem Foundation, Mariebergsgatan 22, 112 35 Stockholm, Sweden. Tel.: +46 73 684 1147; fax: +46 8 617 9333.
  • ,
  • Carol Tishelman

      Affiliations

    • R & D Unit, Stockholms Sjukhem Foundation, Stockholm, Sweden
    • Department LIME, Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
    • School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
  • ,
  • Lars Erik Rutqvist

      Affiliations

    • Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

published online 25 November 2008.

Abstract 

Taste and smell changes (TSCs) are known side effects of chemotherapy, but smell changes (SCs) in the absence of taste changes are understudied. This study aims to explore SCs occurring without taste changes during chemotherapy, to better understand the characteristics of such changes, and how these experiences affect patients in their daily lives.

Data derives from a qualitative interview study and a cross-sectional survey of 518 patients, with all patients receiving out-patient cancer chemotherapy in Sweden. Case studies of three patients with SCs and the 8% of survey participants with SCs only are in focus.

All 43 participants with exclusively SCs reported increased sensitivity to one or several odors, with no participants reporting decreased sensitivity. Those reporting SCs significantly more often reported weight gain than those reporting TSCs, with oral problems and appetite loss significantly less common in the SC group. There were no differences in reported nausea between SC and TSC groups, but nausea was more common in the SC group than in those without TSCs. The case study reports were linked to and discussed in relation to possible explanatory models for increased olfactory sensitivity. SCs increase during chemotherapy, were often unpredictable and led to emotional consequences.

The participants all reported heightened sensitivity to one or several odors which could not fully be explained by the potential explanatory models of anticipatory nausea and vomiting, pseudohallucinations, or increased chemical sensitivity.

Keywords: Olfaction, Signs and symptoms, Cancer, Chemotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1462-3889(08)00131-2

doi:10.1016/j.ejon.2008.10.002

European Journal of Oncology Nursing
Volume 13, Issue 1 , Pages 9-15, February 2009